Could Vical Incorporated (NASDAQ:VICL) Skyrocket? The Stock Had Too Little Sellers

June 14, 2018 - By Michael Lara

Vical Incorporated (NASDAQ:VICL) Logo

The stock of Vical Incorporated (NASDAQ:VICL) registered a decrease of 12.14% in short interest. VICL’s total short interest was 214,900 shares in June as published by FINRA. Its down 12.14% from 244,600 shares, reported previously. With 60,800 shares average volume, it will take short sellers 4 days to cover their VICL’s short positions. The short interest to Vical Incorporated’s float is 2.71%.

The stock decreased 5.31% or $0.06 during the last trading session, reaching $1.07. About 1.08 million shares traded or 469.15% up from the average. Vical Incorporated (NASDAQ:VICL) has declined 29.24% since June 14, 2017 and is downtrending. It has underperformed by 41.81% the S&P500.

Vical Incorporated engages in the research and development of biopharmaceutical products based on its DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases. The company has market cap of $23.34 million. It is developing various DNA vaccines and other therapeutics, such as VCL-HB01 therapeutic vaccine for herpes simplex virus-2 that is in Phase II clinical trial to prevent and protect against lesion recurrence; VL-2397 antifungal program, which is in Phase I clinical trial for the treatment of invasive fungal infections; and CyMVectin prophylactic vaccine for CMV that is in preclinical stage for the prevention of fetal transmission during pregnancy. It currently has negative earnings. The firm also engages in contract manufacturing of plasmid investigational products for various clients.

More notable recent Vical Incorporated (NASDAQ:VICL) news were published by: Benzinga.com which released: “44 Biggest Movers From Yesterday” on June 12, 2018, also Seekingalpha.com with their article: “Vical’s HSV-2 vaccine flunks mid-stage study” published on June 11, 2018, Streetinsider.com published: “Pre-Open Movers 06/11: (GNW) (RCII) (FDC) Higher; (VICL) (PCG) (AAOI) Lower (more…)” on June 11, 2018. More interesting news about Vical Incorporated (NASDAQ:VICL) were released by: Seekingalpha.com and their article: “Vical: No Compelling Reason To Buy” published on June 12, 2018 as well as Nasdaq.com‘s news article titled: “Mid-Afternoon Market Update: Dow Rises 80 Points; Nano Dimension Shares Spike Higher” with publication date: June 11, 2018.

Vical Incorporated (NASDAQ:VICL) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.